Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Korsana Biosciences Appoints Matthew Leoni As Chief Medical Officer and Gan Wei As Chief Technical Officer

RECENTLY ACQUIREDAug 03, 20266 days ago

Position

Chief Medical Officer

Company

Korsana Biosciences

Matthew Leoni, M.D.
WalthamBiotechnologyHealth CareTherapeutics

Description

Korsana Biosciences, Inc. has announced the appointment of Matthew Leoni, M.D., as Chief Medical Officer and Gan Wei, Ph.D., as Chief Technical Officer. These appointments are part of the company's strategy to strengthen its leadership as it enters the next phase of growth.

Company Information

Company

Korsana Biosciences

Location

Waltham, Massachusetts, United States

About

Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary THETA™ therapeutic targeting platform to improve drug delivery and efficacy. Founded in 2024, Korsana aims to elevate patient care by creating potentially best-in-class therapeutics. The company's lead program, KRSA-028, targets amyloid beta and demonstrates strong preclinical data.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Korsana Biosciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.